BR112014002911A2 - linhagem de l. bulgaricus capaz de inibir a adesão de linhagens de h. pylori a células epiteliais - Google Patents
linhagem de l. bulgaricus capaz de inibir a adesão de linhagens de h. pylori a células epiteliaisInfo
- Publication number
- BR112014002911A2 BR112014002911A2 BR112014002911A BR112014002911A BR112014002911A2 BR 112014002911 A2 BR112014002911 A2 BR 112014002911A2 BR 112014002911 A BR112014002911 A BR 112014002911A BR 112014002911 A BR112014002911 A BR 112014002911A BR 112014002911 A2 BR112014002911 A2 BR 112014002911A2
- Authority
- BR
- Brazil
- Prior art keywords
- epithelial cells
- pylori
- lineage
- lines
- bulgaricus
- Prior art date
Links
- 241000186672 Lactobacillus delbrueckii subsp. bulgaricus Species 0.000 title abstract 2
- 210000002919 epithelial cell Anatomy 0.000 title abstract 2
- 230000002401 inhibitory effect Effects 0.000 title abstract 2
- 206010019375 Helicobacter infections Diseases 0.000 abstract 1
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
- A23C9/1238—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt using specific L. bulgaricus or S. thermophilus microorganisms; using entrapped or encapsulated yoghurt bacteria; Physical or chemical treatment of L. bulgaricus or S. thermophilus cultures; Fermentation only with L. bulgaricus or only with S. thermophilus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/746—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for lactic acid bacteria (Streptococcus; Lactococcus; Lactobacillus; Pediococcus; Enterococcus; Leuconostoc; Propionibacterium; Bifidobacterium; Sporolactobacillus)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/123—Bulgaricus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nutrition Science (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
resumo patente de invenção: "linhagem de l. bulgaricus capaz de inibir a adesão de linhagens de h. pylori a células epiteliais". a presente invenção refere-se a uma linhagem de lactobacillus delbrueckii subsp. bulgaricus, apropriada para uso no tratamento ou na prevenção de infecção com helicobacter pylori.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IB2011/053552 WO2013021239A1 (en) | 2011-08-09 | 2011-08-09 | New strain of l. bulgaricus capable of inhibiting the adhesion of h. pylori strains to epithelial cells |
Publications (2)
Publication Number | Publication Date |
---|---|
BR112014002911A2 true BR112014002911A2 (pt) | 2017-03-01 |
BR112014002911B1 BR112014002911B1 (pt) | 2020-12-08 |
Family
ID=44645757
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112014002911-3A BR112014002911B1 (pt) | 2011-08-09 | 2011-08-09 | método para obtenção de uma fração de células e composição que compreende uma linhagem de l. bulgaricus |
Country Status (10)
Country | Link |
---|---|
US (1) | US9272007B2 (pt) |
EP (1) | EP2742125B1 (pt) |
JP (1) | JP5997769B2 (pt) |
CN (1) | CN103987839B (pt) |
AR (1) | AR087463A1 (pt) |
BR (1) | BR112014002911B1 (pt) |
ES (1) | ES2627767T3 (pt) |
MX (1) | MX350212B (pt) |
RU (1) | RU2584600C2 (pt) |
WO (1) | WO2013021239A1 (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9925225B2 (en) * | 2014-09-26 | 2018-03-27 | Nubiome, Inc. | Treatment and prophylaxis for gastroesophageal reflux disease |
CN111118106B (zh) * | 2019-12-20 | 2021-12-17 | 善恩康生物科技(苏州)有限公司 | 一株可以抑制幽门螺旋杆菌的嗜酸乳杆菌la-10a及其应用 |
CN116024129A (zh) * | 2022-11-29 | 2023-04-28 | 光明乳业股份有限公司 | 一株能够与幽门螺杆菌共聚集的卷曲乳杆菌及其应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1148064A1 (en) * | 2000-04-17 | 2001-10-24 | Vrije Universiteit Brussel | Lactobacillus johnsonii bacteriocin, active against Helicobacter pylori |
CN101314763B (zh) * | 2007-06-01 | 2011-06-08 | 统一企业(中国)投资有限公司 | 具有抗胃肠道致病菌、抗氧化和降血压作用的短双歧杆菌及其用途 |
JP5679255B2 (ja) * | 2009-12-28 | 2015-03-04 | 株式会社明治 | 酸素耐性が増強された微生物およびその利用 |
-
2011
- 2011-08-09 RU RU2014108605/10A patent/RU2584600C2/ru active
- 2011-08-09 ES ES11755445.1T patent/ES2627767T3/es active Active
- 2011-08-09 JP JP2014524456A patent/JP5997769B2/ja not_active Expired - Fee Related
- 2011-08-09 US US14/237,740 patent/US9272007B2/en not_active Expired - Fee Related
- 2011-08-09 CN CN201180072799.XA patent/CN103987839B/zh not_active Expired - Fee Related
- 2011-08-09 WO PCT/IB2011/053552 patent/WO2013021239A1/en active Application Filing
- 2011-08-09 MX MX2014001572A patent/MX350212B/es active IP Right Grant
- 2011-08-09 EP EP11755445.1A patent/EP2742125B1/en not_active Not-in-force
- 2011-08-09 BR BR112014002911-3A patent/BR112014002911B1/pt not_active IP Right Cessation
-
2012
- 2012-08-03 AR ARP120102859A patent/AR087463A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ES2627767T3 (es) | 2017-07-31 |
AR087463A1 (es) | 2014-03-26 |
BR112014002911B1 (pt) | 2020-12-08 |
EP2742125B1 (en) | 2017-03-15 |
US20140205571A1 (en) | 2014-07-24 |
CN103987839A (zh) | 2014-08-13 |
JP5997769B2 (ja) | 2016-09-28 |
CN103987839B (zh) | 2016-11-23 |
JP2014522667A (ja) | 2014-09-08 |
RU2014108605A (ru) | 2015-09-20 |
MX2014001572A (es) | 2015-03-05 |
MX350212B (es) | 2017-08-30 |
EP2742125A1 (en) | 2014-06-18 |
US9272007B2 (en) | 2016-03-01 |
WO2013021239A1 (en) | 2013-02-14 |
RU2584600C2 (ru) | 2016-05-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2015095241A3 (en) | Bacterial compositions and methods of use thereof for treatment of immune system disorders | |
BR112013028705A2 (pt) | cepas bacterianas probióticas e composição simbiótica contendo as mesmas destinadas a alimentos para lactentes | |
WO2014018596A3 (en) | Alpha (1,2) fucosyltransferases suitable for use in the production of fucosylated oligosaccharides | |
EP3904502A3 (en) | Compositions and methods | |
SA113340703B1 (ar) | سلالة جديدة من بكتيريا Lactobacillus Crispatus | |
BR112015025256A8 (pt) | Cepas probióticas para uso no tratamento ou prevenção da osteoporose | |
BR112014009866A2 (pt) | formulações de anticorpos e métodos | |
MX2012005524A (es) | Cepa de probioticos bifidobacterium. | |
SG10201901259RA (en) | Prebiotic formulations and methods of use | |
GB2511993A (en) | Prebiotic formulations and methods of use | |
WO2011106322A3 (en) | Biomarkers for acute ischemic stroke | |
BR112012033212A2 (pt) | uso de lactobacillo inibindo a produção de gás de bactéria coliforme isolada em infantes afetados por cólica | |
MY163871A (en) | Vaccines and compositions against streptococcus pneumoniae | |
WO2012138570A3 (en) | Modulating bacterial mam polypeptides in pathogenic disease | |
EA201290623A1 (ru) | Лактобациллы с антиоксидантным действием | |
BR112016023752A2 (pt) | utilização de lactobacillus rhamnosus para promover a recuperação da diversidade da microbiota intestinal após disbiose | |
PH12015500091A1 (en) | Non-pathogenic f18 e.coli strain and use thereof | |
AR068726A1 (es) | Utilizacion de una cepa de bifidobacterium para la preparacion de una composicion destinada a la prevencion o al tratamiento o a ambas cosas a la vez, de manifestaciones de tipo alergico | |
WO2012019054A3 (en) | Expression of antibody or a fragment thereof in lactobacillus | |
MX342226B (es) | Uso de streptococcus salivarius en el tratamiento de infecciones cronicas del tracto respiratorio. | |
CO2017007338A2 (es) | Composición que comprende dos cepas de las especies microbianas lactobacillus rhamnosus y bifidobacterium longum capaces de incrementar la fertilidad masculina | |
BR112014002911A2 (pt) | linhagem de l. bulgaricus capaz de inibir a adesão de linhagens de h. pylori a células epiteliais | |
MX2015005165A (es) | Cepas de streptococcus thermophilus para tratar infeccion por helicobacter pylori. | |
MX349944B (es) | Lactobacillus brevis productor de reuterina. | |
IN2014MN01382A (pt) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] | ||
B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 09/08/2011, OBSERVADAS AS CONDICOES LEGAIS. |
|
B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 11A ANUIDADE. |
|
B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2682 DE 31-05-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |